Skip to Main Content

Paper Details

Understanding the clinical implication of mismatch repair deficiency in endometrioid endometrial cancer through a prospective study.
Gynecol Oncol
6
2021
EC, EEC, EECs, MLH1, MMR protein, MMRd, MMRd tumors, Tumors, cancer, endometrial cancer, endometrioid EC, endometrioid endometrial cancer, mismatch repair deficiency, patient, tumor, tumors
Author NameAffiliation
Raymond H KimUniversity Health Network, Familial Gastrointestinal Cancer Registry, Mount Sinai Hospital, Princess Margaret Cancer Centre, University Health Network/Sinai Health Systems
Blaise A ClarkeUniversity of Toronto
Katherine LajkoszPrincess Margaret Cancer Centre/University Health Network, University of Toronto
Steven GallingerPrincess Margaret Cancer Centre/University Health Network/Sinai Health Systems
Trevor J PughUniversity of Toronto, Canada Ontario Institute for Cancer Research, University Health Network
Trevor J PughUniversity of Toronto, Canada Ontario Institute for Cancer Research, University Health Network
Aaron PollettUniversity of Toronto, Mount Sinai Hospital
  • 1 - 7

Datasets

Release 1.2